logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Fulltext. Counfounding by indication and channeling over time : The risks of bêta2-agonists.

    Article - En anglais

    Fulltext.

    A previously published nested case-control study, the Saskatchewan Asthma Epidemiologic Project (SAEP) spanning 1980-1987, investigated the risk of fatal or near fatal asthma and found different risks for two inhaled bêta2-agonists, fenoterol and salbutamol.

    The authors assessed whether this comparison was confounded by indication because of channeling of inhaled fenoterol to more severely afflicted asthmatics.

    Using three subcohorts selected from a cohort of 12,301 asthmatics assembled from the computerized databases of Saskatchewan Health and followed over 7 years, the authors studied two forms of channeling and investigated whether greater asthma severity and less well-controlled disease were associated with preferential prescribing of a first prescription of inhaled fenoterol, as opposed to inhaled salbutamol, and whether they were associated with the likelihood of a switch from inhaled salbutamol to fenoterol as well as a switch from inhaled fenoterol to salbutamol.

    The authors found that the initial choice between fenoterol and salbutamol was independent of the severity of the asthma and disease control, but that preferential prescribing of fenoterol occurred among users of salbutamol who showed signs of increased severity or uncontrolled asthma.

    The switch from inhaled fenoterol to salbutamol was, however, minimally related to asthma severity. (...)

    Mots-clés Pascal : Fénotérol, Salbutamol, Bronchodilatateur, Chimiothérapie, Traitement, Asthme, Toxicité, Mort, Indice gravité, Indication, Agoniste, Récepteur bêta2-adrénergique, Etude comparative, Biais méthodologique, Canada, Amérique du Nord, Amérique, Homme, Appareil respiratoire pathologie, Bronchopneumopathie obstructive, Allergie, Immunopathologie, Epidémiologie, Méthodologie, Facteur confondant

    Mots-clés Pascal anglais : Fenoterol, Salbutamol, Bronchodilator, Chemotherapy, Treatment, Asthma, Toxicity, Death, Severity score, Indication, Agonist, bêta2-Adrenergic receptor, Comparative study, Methodological bias, Canada, North America, America, Human, Respiratory disease, Obstructive pulmonary disease, Allergy, Immunopathology, Epidemiology, Methodology

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0069958

    Code Inist : 002B02U07. Création : 21/05/1997.